Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

Objectives Early diagnosis and reducing the time taken to achieve each step of lung cancer care is essential. This scoping review aimed to examine time points and intervals used to measure timeliness ...

This important study shows a significant role for Musashi-2 (Msi2) in lung adenocarcinoma. The authors provided solid data that support the requirement for Msi2 in tumor growth and progression, ...

In the published article, there was an error in the Funding statement. The corresponding author’s funding was inadvertently omitted. The correct Funding statement ...

database and MARCH9 expression was assessed by individual cancer stage (stage 1-stage 4), histological subtype (adenocarcinoma and mucinous adenocarcinoma), and nodal metastasis status (N0-N2).